Endoluminal suturing devices are widely used in open surgeries, abdominal surgeries, endoscopy, and other gastrointestinal surgeries. Over the years, the affordability and accessibility to surgical care have increased, leading to a significant rise in the number of surgical procedures performed utilizing suturing devices. The increasing prevalence of lifestyle diseases and the subsequent rise in surgical procedures have further increased the demand for advanced surgical equipment, including suturing devices.
Wound closure devices such as staplers, ligating clips, and wound closure strips and sealing agents, skin adhesives, and hemostats are prominent alternatives associated with certain advantages to surgical sutures. For instance, stapling is quicker than suturing. Due to their efficiency and benefits over surgical sutures, the availability of alternatives is a key restraint for the endoluminal suturing devices market.
Emerging countries (such as China, Brazil, Mexico, and India) present significant growth opportunities for players in the endoluminal suturing devices market. The demand for endoluminal suturing devices in these countries is increasing owing to the rapid growth in the healthcare infrastructure, increasing public and private healthcare expenditure, and growth in medical tourism.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=250924884
Additionally, the rising number of skilled surgeons and a sharp rise in gastrointestinal surgical procedures across these countries contribute to overall demand growth. Other emerging countries are also witnessing rapid modernization in their healthcare facilities and the expansion of their healthcare infrastructure. This factor contributes to the increasing procurement of medical devices and surgical instruments.
Rising medical tourism in the emerging countries, due to the low cost of surgical treatment options, also presents new growth avenues for endoluminal suturing device providers.
Currently, the lack of skilled surgeons in developed and developing economies is one of the major factors limiting the adoption of endoluminal suturing devices. While the demand for surgeons is steadily increasing, the supply of future surgeons is not rising at the same rate.
Based on application, the endoluminal suturing devices market is segmented into bariatric surgery, gastrointestinal surgery, gastroesophageal reflux disease surgery, and other surgeries. The largest share of the gastrointestinal surgery segment can be attributed to the growing adoption of endoluminal suturing devices for the growing number of gastrointestinal cancer cases worldwide and the increasing prevalence of gastrointestinal disorders.
The global endoluminal suturing devices market is projected to reach USD 139 million by 2027 from USD 78 million in 2022, at a CAGR of 12.0%. Growth in this market is majorly driven by the rising prevalence of gastrointestinal cancers, inflammatory bowel disease, and other digestive diseases and the increasing number of surgical procedures worldwide.
Key Market Players
Major players in the endoluminal suturing devices market are Apollo Endosurgery, Inc. (US), Johnson & Johnson (US), Medtronic Plc (Ireland), Cook Group Incorporated (US), USGI Medical (US), Ovesco Endoscopy AG (Germany), Endo Tools Therapeutics S.A. (Belgium), ErgoSuture (US), and Sutrue Ltd. (UK).